[ACRX] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
12-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -22.61%
YoY- -65.13%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 548 407 940 1,675 166 224 329 40.47%
PBT -10,986 -17,447 -12,762 -33,363 -8,582 -6,596 -7,065 34.18%
Tax -1,980 -9,273 -1,285 -22,841 390 248 519 -
NP -10,986 -17,447 -12,762 -10,522 -8,582 -7,194 -7,065 34.18%
Tax Rate - - - - - - - -
Total Cost 11,534 17,854 13,702 12,197 8,748 7,418 7,394 34.46%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin -2,004.74 -4,286.73 -1,357.66 -628.18 -5,169.88 -3,211.61 -2,147.42 -4.47%
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
EPS -5.30 -9.36 -6.87 -5.67 -7.58 -6.98 -7.21 -18.53%
EPS Diluted -5.30 -9.36 -6.87 -5.67 -7.58 -6.98 -7.21 -18.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.